概要
February 8-10: Forum
As regulatory operations continue to evolve, organizations are increasingly being challenged to move beyond document-centric processes toward more connected and data-enabled ways of working. Success today depends not only on the ability to prepare and deliver high-quality submissions, but also on how effectively organizations manage information, structure data, optimize processes, and align the people, systems, and technologies that support regulatory work.
At DIA’s Regulatory Submissions, Information, and Data Management (RSIDM) Forum, industry and regulatory stakeholders come together to examine the standards, requirements, technologies, and approaches shaping the current and future state of regulatory operations. While the RSIDM acronym remains unchanged and continues to reflect the Forum’s established identity, the inclusion of “Data” in the meeting name more accurately reflects the growing importance of data in regulatory submissions, information management, process improvement, and technology adoption.
Through four focused tracks, the Forum provides practical insights on how to build and sustain strong RSIDM foundations, optimize processes and procedures, adopt innovative technologies, and strengthen strategic leadership and organizational readiness. The Forum also offers opportunities for education, networking, and knowledge sharing for both business- and technology-focused professionals at all levels.
While we develop our 2027 agenda, please take a moment to review the 2026 final agenda
Featured
Want to learn more about Regulatory Submissions, Information, and Data Management Forum? You've come to the right site!
プログラム委員会
-
Nimesh Patel Senior Director of Global Regulatory Systems
Eisai Co., Ltd., United States -
Noelia Plaza Director of Process Excellence & Analytics
Daiichi Sankyo, United States -
Jonathan Resnick, PMP Advisor, Office of Digital Transformation
FDA, United States -
Karin Schneider, MLIS, MS Associate Director
Johnson & Johnson, United States -
Alisa Amirova Manager, Regulatory Information Management & Technology (RIMT)
Biomarin Pharmaceutical, United States -
Vladimir Penkrat, MBA
Indegene, United States -
Venkatraman Balasubramanian, MBA Healthcare and Life Sciences Strategic Advisor
VB Insights, LLC, United States -
Kunal Lal, MBA Consultant - Strategy & Change
Red Nucleus, United Kingdom -
Shenqi (Handsome) Ji Publishing Regional Director, Asia, Global Regulatory & International Operations
Pfizer, China -
Seyoum Senay, MS Supervisory Operations Research Analyst, CDER/OBI
FDA, United States -
Lorelle Leonienco, PMP Product Manager
LORENZ Life Sciences Group, United States -
Jennifer Dames Director, RA Submission Management
AbbVie, United States -
Katherine Novak, MS Director
Epista Life Science, United States -
Rachel Bombara Sr. Regulatory Services Manager
Certara, United States -
Aliza Nathoo Senior Director, Content Strategy
Hoffmann-La Roche Limited, Canada -
Rita Algorri, PHD, MS Associate Director, Global Regulatory Affairs (CMC)
Amgen, United States -
Ashley Jones-Mitchell, MPH Head of Global Regulatory Policy
Accumulus Synergy, United States -
Lindsay Fitzgerald Delivery Manager
Astrix, United States -
Theresa Pinnell, MLS Director of Regulatory Solutions
Kivo, United States -
Kevin Tompkins, MBA Executive Director, Regulatory Information & Submission Management
Bristol Myers Squibb, United States -
John Popp, PHD Senior Manager - Regulatory Information Management
Celegence, Netherlands -
Jasmine Gupta Global Regulatory Affairs Lead
Synthekine, United States